Concepedia

Qin Ryan

QR

9

Publications

1.2K

Citations

9

H-Index

2003

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

Center for Drug Evaluation and Research

United States Food and Drug Administration

Centers for Medicare and Medicaid Services

Qin Ryan is an author at National Cancer Institute specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2003–2016

9

Publications

9

Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma

Qin Ryan, Donna Headlee, Milin Acharya et al. · Journal of Clinical Oncology · 2005 · 406 citations · Full text

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2

Qin Ryan, Amna Ibrahim, Martin H. Cohen et al. · The Oncologist · 2008 · 303 citations · Full text

Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products

Cunlin Wang, David J. Graham, Robert C. Kane et al. · JAMA · 2015 · 210 citations · Full text

Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies

Shivaani Kummar, Martin Gutierrez, Erin R. Gardner et al. · Clinical Cancer Research · 2007 · 130 citations · Full text

Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare

Cunlin Wang, Robert C. Kane, Mark Levenson et al. · JAMA Internal Medicine · 2016 · 39 citations · Full text

Rows per page

1–5 of 9